Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis.
Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.
Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
Effects Of A Novel Orally Administered Calpain Inhibitor Snj-1945 On Immunomodulation And Neurodegeneration In A Murine Model Of Multiple Sclerosis.
Role of Immune Cells in the Course of Central Nervous System Injury: Modulation with Natural Products.
Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
The common marmoset as a novel animal model system for biomedical and neuroscience research applications.
Erythromelalgia-like presentation of chronic acquired demyelinating polyneuropathy in a setting of past alcohol abuse.
Neuroimaging and cognition using functional near infrared spectroscopy (fNIRS) in multiple sclerosis.
Procedural Variations in the Stroop and the Symbol Digit Modalities Test: Impact on Patients with Multiple Sclerosis.
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis.
Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin.
[Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]
The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages.
Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study.
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.
Evidence for classic complement activity in neuromyelitis optica.
HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis.
Meningeal and Choroid Plexus Cells - Novel Drug Targets for CNS Disorders.
An introduction with medical applications to functional data analysis.
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells.
Re-expression of N-cadherin in remyelinating lesions of experimental inflammatory demyelination.
Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain.
Pages
« first
‹ previous
…
250
251
252
253
254
255
256
257
258
…
next ›
last »